RenalSense is a leading medical technology company based in Brookline, MA, specializing in renal function monitoring systems for patients at risk of Acute Kidney Injury (AKI) in the ICU. Their flagship product, Clarity RMS, continuously measures urine flow and transmits real-time data and notifications to healthcare professionals, enabling early detection of changes in renal function and facilitating rapid intervention.
With its automatic measurements and reliable data, Clarity RMS provides accurate readings of urine flow, reducing the risk of contamination and human error. The system also offers full connectivity to hospital information systems, ensuring continuous transmission of data. RenalSense's innovative technology improves medical care by enabling early intervention, monitoring treatment efficacy, and managing fluid balance, ultimately leading to better patient outcomes and improved ICU efficiency.
Generated from the website